EAM Investors’s Amedisys AMED Stock Holding History

EAM Investors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,581	Closed	-$2.68M	–	257
2020 Q1	$2.68M	Sell	14,581 -79	-0.5%	-$14.1K	0.83%	21
2019 Q4	$2.45M	Buy	+14,660	New	+$2.18M	0.54%	54
2019 Q1	–	Sell	-12,621	Closed	-$1.48M	–	254
2018 Q4	$1.48M	Sell	12,621 -5,215	-29%	-$615K	0.4%	112
2018 Q3	$2.23M	Sell	17,836 -23,076	-56%	-$2.55M	0.33%	144
2018 Q2	$3.5M	Buy	+40,912	New	+$3M	0.55%	47
2016 Q3	–	Sell	-49,680	Closed	-$2.51M	–	295
2016 Q2	$2.51M	Buy	+49,680	New	+$2.51M	0.38%	139
2016 Q1	–	Sell	-16,703	Closed	-$657K	–	296
2015 Q4	$657K	Sell	16,703 -3,560	-18%	-$142K	0.09%	300
2015 Q3	$769K	Sell	20,263 -9,869	-33%	-$416K	0.12%	279
2015 Q2	$1.2M	Sell	30,132 -5,598	-16%	-$174K	0.14%	277
2015 Q1	$957K	Sell	35,730 -14,065	-28%	-$397K	0.11%	306
2014 Q4	$1.46M	Sell	49,795 -6	-0%	-$148	0.2%	228
2014 Q3	$1M	Buy	+49,801	New	+$961K	0.2%	257

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAM Investors's AMED Position: Q2 2020 in Review

EAM Investors sold out of Amedisys (AMED) in Q2 2020, closing a stake of 14,581 shares — an estimated $2.68M sold.

EAM Investors first reported a position in AMED in Q3 2014 and held it in 12 quarters. The position peaked at $3.5M in Q2 2018. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

EAM Investors reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
EAM Investors sold 14,581 Amedisys shares in Q2 2020, an estimated $2.68M.
EAM Investors first reported a position in Amedisys in Q3 2014 and held it in 12 quarters.
EAM Investors's Amedisys position peaked at $3.5M in Q2 2018.
354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.